Table of Contents

company-logo

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by Streptococcus pneumoniae; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; and Nexterone, a captisol-enabled formulation of amiodarone; and Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Bryxta and Zybev for various indications; and Minnebro for the treatment of hypertension. The company's partners and licenses programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver and kidney disease, and other diseases. Further, it sells Captisol materials. The company was incorporated in 1987 and is headquartered in Emeryville, California.

Ligand Pharmaceuticals Dividend Announcement

• Ligand Pharmaceuticals announced a annually dividend of $0.12 per ordinary share which will be made payable on . Ex dividend date: 2010-07-02
• Ligand Pharmaceuticals 's trailing twelve-month (TTM) dividend yield is -%

Ligand Pharmaceuticals Dividend History

Ex-Div dateDividend amountDividend typePay date
2010-07-02$0.12annually
2007-04-03$2.50annually2007-04-19

Ligand Pharmaceuticals Dividend per year

Ligand Pharmaceuticals Dividend Yield

Ligand Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Ligand Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Ligand Pharmaceuticals Financial Ratios

P/E ratio47.36
PEG ratio-0.49
P/B ratio2.55
ROE5.79%
Payout ratio0.00%
Current ratio12.49
Quick ratio11.95
Cash Ratio2.57

Ligand Pharmaceuticals Dividend FAQ

Does Ligand Pharmaceuticals stock pay dividends?
Ligand Pharmaceuticals does not currently pay dividends to its shareholders.
Has Ligand Pharmaceuticals ever paid a dividend?
No, Ligand Pharmaceuticals has no a history of paying dividends to its shareholders. Ligand Pharmaceuticals is not known for its dividend payments.
Why doesn't Ligand Pharmaceuticals pay dividends?
There are several potential reasons why Ligand Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Ligand Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Ligand Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Ligand Pharmaceuticals a dividend aristocrat?
Ligand Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Ligand Pharmaceuticals a dividend king?
Ligand Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Ligand Pharmaceuticals a dividend stock?
No, Ligand Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Ligand Pharmaceuticals stocks?
To buy Ligand Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Ligand Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.